IPL treatment — relief from dry eye
Dry eye disease and chronic blepharitis are inflammatory conditions of the eye's surface, often caused by meibomian gland dysfunction. For a long time, they were treated only with artificial tears or anti-inflammatory drugs. Since 2002, thanks to the work of Dr Russell Toyos in ophthalmology, IPL (Intense Pulsed Light) treatment has expanded the available care. At the OPHTALIFE practice in Boulogne-Billancourt, just outside Paris, I offer a 4-session protocol that targets the underlying mechanisms: liquefying clogged secretions, destroying abnormal blood vessels, eliminating Demodex mites and modulating inflammation. The result: a gradual and lasting improvement in comfort.
What is IPL?
IPL (Intense Pulsed Light) is a non-ablative technology that originated in dermatology and is now used in ophthalmology to treat meibomian gland dysfunction. I have also written a blog article about this technology: “IPL for dry eyes: the complete guide”.
Definition & technology
IPL emits polychromatic light covering a range of wavelengths: 500 to 1200 nanometers. Unlike a laser (a single wavelength), this spectral diversity allows a multifactorial, non-invasive action on the eyelid and periorbital tissues.
The light is delivered in short pulses (a few milliseconds), with precisely controlled intensity and duration. It penetrates the skin to a depth of a few millimeters, generating localized heat without abrading the surface.
IPL is a non-invasive, outpatient treatment: no incision, no stitches, no recovery time.
History in ophthalmology
IPL has been used in dermatology since the 1990s to treat acne, rosacea and erythema. In 2002, Dr Russell Toyos (United States) had the idea of applying it to ocular rosacea and meibomian gland dysfunction. Since then, more than 20 years of publications have supported its effectiveness.
I have offered this treatment since 2023 at the OPHTALIFE practice, always guided by the OSDI score, a comprehensive ocular surface assessment (TBUT, fluorescein, meibography), and the indications validated by professional societies (TFOS DEWS II, SFO).
IPL is not a cure-all, but it is a key tool in the stepwise management of dry eye disease.
The 4 mechanisms of action of IPL
IPL acts simultaneously on four disease processes, which explains its overall and lasting effectiveness on dry eye disease and blepharitis.
Meibum liquefaction
The heat generated by IPL raises the eyelid temperature to about 40-45 °C — above the melting point of meibomian secretions, which are abnormally thick in MGD. They liquefy and regain their fluidity for the manual expression that follows (Borchman 2011, Goldberg 2014).
Selective photothermolysis
IPL targets the dilated, abnormal blood vessels (telangiectasias) responsible for redness and rosacea. The heat partially destroys them, reducing chronic inflammation.
Thermal elimination
Demodex mites colonize the eyelash follicles. IPL reduces the Demodex population, thereby lowering the overall inflammatory burden (Cheng 2019, Zhang 2019).
Immune modulation
IPL reduces pro-inflammatory cytokines (TNF-α, IL-6, IL-8) and MMP-9. This lasting anti-inflammatory effect improves the ocular surface.
Indications & contraindications
IPL is not for everyone. A consultation is essential to assess your eligibility and optimize the results.
- Moderate to severe meibomian gland dysfunction (MGD)
- Chronic posterior blepharitis
- Ocular rosacea (redness, telangiectasias)
- Refractory dry eye disease (not responding to artificial tears)
- Dry eye after LASIK or PRK
- Confirmed or suspected demodicosis
- Chronic functional tearing
- Anterior blepharitis associated with seborrheic dermatitis
- Skin phototype VI — very dark skin (risk of burns)
- Recent tan (less than 2 weeks)
- Photosensitizing drugs: isotretinoin, tetracyclines
- Pregnancy (relative contraindication — to be discussed)
- History of lupus, photodermatosis or porphyria
- Melanoma or suspicious pigmented lesion around the eye
- Photosensitive epilepsy
- Uncontrolled herpes simplex in the treatment area
- Hypertrophic scarring (history of keloids)
Important: Skin phototypes V and VI are not absolute contraindications. Adjusting the settings (reduced fluence, skin masking) can make treatment possible. A thorough consultation is mandatory.
The 4-session protocol
Regular spacing, cumulative effects, clinical follow-up. Here is how we structure your IPL treatment at the practice.
A full OSDI assessment, TBUT (tear break-up time) test, fluorescein and lissamine green staining, and meibography. Discussion of your expectations. First IPL session with settings adapted to your skin phototype and severity. Manual expression of the meibomian glands after IPL.
Quick clinical check (slit lamp). Second IPL session with a slight increase in fluence depending on tolerance. Gland expression. Liquefaction of the meibum starts to become visible.
Assessment of clinical signs (redness, perceived dryness). Third IPL session at optimal intensity. This session consolidates the anti-inflammatory effect and continues the elimination of Demodex.
Final IPL session, completing the protocol. Post-treatment ocular surface assessment (staining, TBUT, osmolarity). Recommendations for long-term maintenance.
Clinical follow-up visit and OSDI questionnaire. If progress is good, annual maintenance is possible. In case of partial recurrence at 6-12 months, a second series of 2-4 sessions may be offered.
What happens during a session
15 simple, painless minutes. Here is exactly what happens at the practice.
You are seated comfortably in a suitable examination chair, in a semi-reclined position, tilted slightly backward.
The eyelids are carefully cleansed with a gentle lotion. All cosmetic residue is removed, which is important for the IPL light to penetrate effectively.
I place two sterile, opaque metal eye shields, specifically designed for ophthalmic IPL, which fully protect the eyes and lashes. You may perceive a faint glow through your closed eyelids, but no direct light enters the eye.
A generous layer of clear, cold coupling gel is applied to the lower eyelids and periorbital area. This gel helps transmit the light and cools the skin, reducing discomfort.
I guide the handpiece (applicator) over the eyelids. You will feel tingling and a light elastic-band “snap” with each pulse — a tolerable sensation, 2-3/10 on the pain scale. Duration: about 10 minutes for both eyes.
After removing the gel, I perform manual expression of the meibomian glands (MGX) using dedicated forceps (Maskin or Mastrota). It is painless and allows the liquefied secretions to be cleared.
The protective shields are removed and the gel is cleaned off. I apply SPF 50 sunscreen to the treated eyelids.
Immediate return to activities. You leave the practice and carry on with your day as normal. A few tips: avoid chlorinated water for 48h, wear sunglasses, make-up is possible after 24h.
Ready to improve your eye comfort?
Book a consultation for a full OSDI assessment and a first IPL session. 15 minutes to start your transformation.
Sensations & experience
During the session
During the session, your eyes are protected by the opaque metal shields. Most patients describe:
- Mild tingling on the eyelids
- A light elastic-band snap with each pulse
- A pleasant feeling from the cold gel at first, then slight warmth
- A mild, well-tolerated sensation for the vast majority of patients
- A very faint smell of heat — this is normal
After the session
You leave the practice with no restrictions on activity:
- Eyelid erythema (redness): present for 24-48 hours, then fades
- No significant swelling (mild at most)
- Mild tearing possible during the first few hours (normal)
- Make-up: wait 24 hours
- Contact lenses: a 48-hour wait is recommended
- Sports, swimming: resume immediately
- SPF 50 is mandatory on the treated area for 1 week
Important advice: Apply a gentle moisturizer after 24 hours. Avoid chlorinated water and very hot water (showers). These precautions support optimal skin healing.
What results can you expect?
IPL is not a permanent cure, but it provides lasting stabilization of the ocular surface. Here is a realistic timeline.
During the protocol, a slight improvement in subjective symptoms (less stinging). Clinical signs improve gradually (less eyelid redness).
Noticeable improvement. The OSDI score drops (fewer symptoms). You notice less stinging at the end of the day, better tolerance of screens and more comfortable night driving.
Optimal results. Increased TBUT (more stable tears), improved staining tests, normalized osmolarity. How you feel overall: eyes that feel “free,” with lasting, noticeable everyday comfort.
Results are maintained. Depending on the initial severity, the benefits remain stable for 6-12 months or even longer. In case of mild recurrence, a maintenance course of 1-2 sessions can reinforce the effect.
A realistic view: IPL is not a “permanent cure” but an effective treatment for a chronic condition that stabilizes meibomian gland dysfunction. As with most chronic inflammatory diseases of the ocular surface (dry eye, blepharitis), the goal of treatment is to stabilize rather than to cure. Annual maintenance is often recommended for more severe cases.
The scientific evidence
IPL is not a gimmick. Since 2002, more than 20 years of peer-reviewed publications have supported its clinical effectiveness and its mechanisms of action.
Proven effectiveness
The Cochrane systematic review protocol by Cote et al. (2020) and subsequent reviews report low- to moderate-quality evidence in favor of IPL for meibomian gland dysfunction, with improvements in TBUT and OSDI; the published protocols remain highly heterogeneous.
The retrospective observational study by Toyos et al. (2015, Photomed Laser Surg) reports symptom improvement in most patients treated with IPL combined with meibomian gland expression (MGX). This is the landmark study that popularized IPL in ophthalmology; the first randomized controlled trial is Craig et al. (2015, IOVS).
Craig et al. (2015), a prospective, randomized, split-face study in New Zealand (n = 28): IPL significantly improved TBUT, lipid layer quality and symptoms compared with the control side.
The retrospective series by Vegunta et al. (2016, Cornea) reports good results with combined IPL + meibomian gland expression (MGX). It has no IPL-only arm, so this study does not formally demonstrate the superiority of the combination — it is nevertheless the protocol I use routinely at the practice.
The literature review by Fineide et al. (Acta Ophthalmologica, 2024) summarizes around fifty studies: a favorable effect on MGD, heterogeneous levels of evidence, and exceptionally rare serious adverse effects.
In 2023, I published a major literature review entitled EYERUBBICS: The Eye Rubbing Cycle Study in the Journal of Clinical Medicine (DOI 10.3390/jcm12041529). With the team at the CHNO des Quinze-Vingts (Paris) and Prof. Christophe Baudouin, we showed how dry eye creates a vicious circle of eye rubbing, which in turn worsens inflammation and tear film instability.
This understanding is crucial: IPL does not treat meibomian gland dysfunction in isolation. It also breaks this vicious circle by reducing inflammation (less urge to rub) and stabilizing the tears (less of the gritty sensation that triggers rubbing), and so quickly restores your comfort. That is why I recommend IPL early in the course of care, as soon as dry eye is confirmed.
Quiz — Is IPL right for you?
5 quick yes/no questions to assess your eligibility for IPL. Instant result.
Your eligibility score
Book an assessment ↗Fees & reimbursement
Coverage
French national health insurance (Assurance Maladie): IPL is not covered by the national health insurance (except in very specific, extremely rare cases of severe eye disease).
Complementary health insurance (mutuelle): Depending on your policy, some mutuelles offer a partial allowance (30-50%) for aesthetic or anti-inflammatory treatments. Check with your insurer.
Quote: You will receive a detailed quote at your first consultation, before treatment begins.
Benefits of the investment
- Lasting improvement (6-12 months minimum)
- Major reduction in the use of artificial tears
- Better quality of life (comfortable screen use, easier driving)
- Non-invasive, outpatient treatment
- Serious complications are very rare (isolated cases of uveitis, skin burns if the skin phototype is misjudged, temporary lash depigmentation)
Book a consultation for a personalized quote and to explore the options offered by your mutuelle.
Patient journey — 4 steps
You describe your symptoms to me. I carry out a full OSDI assessment, TBUT test, fluorescein staining, meibography and osmolarity. Together we discuss the benefits of IPL and the alternatives. Quote.
Sessions are spaced 15 days apart. Mechanical gland expression is performed systematically after IPL. No major constraints: immediate return to activities. You start to notice an improvement from month 1.
Visit at month 3 with OSDI assessment and clinical tests. Effectiveness check. If the result is excellent, transition to preventive maintenance.
Annual visit (or every 6-12 months, depending on the case). A “booster” session is possible in case of mild recurrence. This way, you keep your comfort over the long term.
FAQ — IPL & dry eye
Meibomian gland dysfunction is a chronic and progressive condition. A single IPL session produces only a temporary effect. Four sessions allow a gradual build-up of effects: increasing liquefaction of the meibomian secretions, a reduction in the Demodex population and, above all, lasting anti-inflammatory modulation. The spacing (2 weeks between sessions) is what allows the glands to “recover” gradually.
The first signs of improvement often appear at 1-2 months (less stinging at the end of the day, better tolerance of screens). The optimal plateau is reached 3 months after the last session. The benefits appear gradually, with no dramatic immediate effect.
No, no anesthesia is needed. IPL causes mild discomfort (2-3/10): tingling and a light elastic-band “snap.” It is well tolerated by the vast majority of patients, and the skin gets used to it over the sessions. The cold gel helps keep you comfortable during the session.
Yes, you can return to your activities immediately. No incision, no stitches, no internal inflammation. The only precaution: avoid chlorinated water for 48 hours (risk of irritating the treated skin). Swimming in the sea or in fresh water is possible after 48h. Dry-land sports: no waiting period.
Make-up: Wait 24 hours before applying eye make-up. After 24h, no restrictions. Contact lenses: Wait 48 hours after each session before putting your lenses back in. Glasses: no waiting period.
The risk is very low, provided the eye protection is correctly positioned. The opaque shields I place under the eyelids provide complete mechanical protection of the intraocular structures (cornea, lens, retina). IPL is applied only to the skin of the lower eyelids and the periorbital area, never directly facing the open eye. In addition, the device's optical filters block the most penetrating wavelengths (< 500 nm).
This is a relative contraindication. Phototypes V-VI have more melanin, which absorbs more of the IPL light and increases the risk of skin burns. But IPL is not entirely ruled out: reducing the fluence (intensity) and sometimes masking the skin can make treatment feasible. A thorough consultation is mandatory to weigh the risks and benefits.
The results last at least 6 to 12 months, often longer depending on the initial severity and your lifestyle. IPL is not a permanent cure, but it provides lasting stabilization of meibomian gland dysfunction. Annual maintenance (1-2 sessions) is often offered to maintain comfort. This is the typical approach for chronic inflammatory conditions: the aim is to stabilize rather than to cure.
Ready to improve your visual comfort for the long term?
IPL treats the root cause of evaporative dry eye. A comprehensive ocular surface assessment allows me to confirm the indication and design a personalized 4-session protocol with you.
Related pages
Explore other ocular surface conditions and related treatments.
Scientific references
This page is based on international guidelines and key publications in ophthalmology. All sources can be verified.
-
1
Cote S, Bosc R, Mantelli F, et al. Intense pulsed light (IPL) therapy for the treatment of meibomian gland dysfunction. Cochrane Database Syst Rev. 2020;3(3):CD013559.
-
2
Fineide F, Magnø MS, Khan AZ, et al. Intense pulsed light treatment in meibomian gland dysfunction: Past, present, and future. Acta Ophthalmol. 2024;102(4):e414-e442.
-
3
Toyos R, McGill W, Briscoe D. Intense pulsed light treatment for dry eye disease due to meibomian gland dysfunction; principles and case reports. Photomed Laser Surg. 2015;33(1):41-46.
-
4
Craig JP, Chen YH, Turnbull PR. Prospective trial of intense pulsed light for the treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci. 2015;56(3):1965-1970.
-
5
Vegunta S, Patel D, Shen JF. Combination therapy of intense pulsed light therapy and meibomian gland expression (IPL/MGX) can improve dry eye symptoms and meibomian gland function in patients with refractory dry eye: a retrospective analysis. Cornea. 2016;35(3):318-322.
-
6
Jones L, Downie LE, Korb D, et al. TFOS DEWS II Management and Therapy Report. Ocul Surf. 2017;15(3):575-628.
-
7
Hage A, Knoeri J, Leveziel L, Majoulet A, Blanc J-V, Buffault J, Labbé A, Baudouin C. EYERUBBICS: The Eye Rubbing Cycle Study. J Clin Med. 2023;12(4):1529.
The content of this website is for information only and is not a substitute for a medical consultation. Any treatment decision should be made together with your ophthalmologist.